Factors associated with optimized tacrolimus dosing in hematopoietic stem cell transplantation
Conclusion
An initial flat tacrolimus dose of 1 mg IV daily is a suboptimal approach to achieve therapeutic levels at this institution. A dose of 1.6 mg or 2 mg IV daily is a reasonable alternative to the current institutional practice.
Source: Journal of Oncology Pharmacy Practice - Category: Cancer & Oncology Authors: Butts, A. R., Brown, V. T., McBride, L. D., Bolanos-Meade, J., Bryk, A. W. Tags: Original Articles Source Type: research
More News: Cancer & Oncology | Prograf | Statistics | Stem Cell Therapy | Stem Cells | Tacrolimus | Transplants